<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://www.um.edu.mt/library/oar/handle/123456789/40722">
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/40722</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://www.um.edu.mt/library/oar/handle/123456789/41040" />
        <rdf:li rdf:resource="https://www.um.edu.mt/library/oar/handle/123456789/41039" />
        <rdf:li rdf:resource="https://www.um.edu.mt/library/oar/handle/123456789/41038" />
        <rdf:li rdf:resource="https://www.um.edu.mt/library/oar/handle/123456789/41037" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-05T01:43:43Z</dc:date>
  </channel>
  <item rdf:about="https://www.um.edu.mt/library/oar/handle/123456789/41040">
    <title>Homeopathy and allied therapies : a review</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/41040</link>
    <description>Title: Homeopathy and allied therapies : a review
Authors: Attard, Everaldo
Abstract: Homeopathy is the basis of several forms of therapies&#xD;
that emerged later on throughout Europe. Homeopathy&#xD;
and these related therapies form part of Europe’s&#xD;
traditional medical history. Several physicians followed&#xD;
Hahnemann’s principles and applied them to their forms&#xD;
of therapies. Such therapies include anthroposophic&#xD;
medicine, gemmotherapy, lithotherapy, organotherapy,&#xD;
Bach’s floral remedies, Schüssler’s tissue salts. However,&#xD;
in the multicultural and modern Europe, there is still a&#xD;
long way for the official recognition and harmonisation&#xD;
of products within the European Union Member States.&#xD;
Due to popularity of these remedies with EU citizens, the&#xD;
European centralised body and individual Member States&#xD;
medicines authorities are obliged to safeguard the general&#xD;
public through the assessment of safety and quality of&#xD;
these medicinal products.</description>
    <dc:date>2011-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://www.um.edu.mt/library/oar/handle/123456789/41039">
    <title>Generic medicine prices and their distribution in Malta</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/41039</link>
    <description>Title: Generic medicine prices and their distribution in Malta
Authors: Vella, John; Zarb Adami, Maurice
Abstract: Objectives: To analyse the composition of the&#xD;
private pharmaceutical retail market in Malta on the basis&#xD;
of the originator or generic status of available medicines&#xD;
and to observe the change in prices of generics and&#xD;
originators over time.&#xD;
Method: The prices of a sample (n=435) of medicines&#xD;
in Malta were analysed for an eight year period (2002 to&#xD;
2009). The variation in price in the generic and originator&#xD;
segments was calculated. Thirty-one active ingredients&#xD;
with generics available were identified and the Average&#xD;
Retail Price Per Unit (ARPPU) and the Lowest Retail Price&#xD;
Per Unit (LRPPU) were calculated. The average discount&#xD;
from the originator price was calculated, per compound&#xD;
and also by drug class.&#xD;
Key Findings: The sample population contained&#xD;
17.2% generic products. The mean drop in the ARPPU was&#xD;
of 10.87% and for the LRPPU of 21.42% for the LRPU. The&#xD;
average discount was 14.59% in 2002 and 37.19% in 2009.&#xD;
Conclusion: The number of generic medicines&#xD;
in Malta has increased in the last eight years, with a&#xD;
consequent decrease in the lowest prices available for the&#xD;
set of medicinal compounds.</description>
    <dc:date>2011-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://www.um.edu.mt/library/oar/handle/123456789/41038">
    <title>A pilot study to determine the cost of pharmaceutical drug treatment for chronic conditions prescribed in relation to patients' age</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/41038</link>
    <description>Title: A pilot study to determine the cost of pharmaceutical drug treatment for chronic conditions prescribed in relation to patients' age
Authors: Galea, Monica; Zarb Adami, Maurice
Abstract: Objective: To determine the age distribution of&#xD;
patients and the total drug cost. To establish the average&#xD;
cost per age group and identify factors that may influence&#xD;
cost.&#xD;
Method: A pilot study was conducted by selecting&#xD;
by convenience sampling a number of patients over 18&#xD;
years who were registered in the Pharmacy of Your Choice&#xD;
scheme with a community pharmacy where the study was&#xD;
carried out. For each patient, type, frequency and cost&#xD;
of medication supplied were identified from treatment&#xD;
cards and from Government Health Procurement Services&#xD;
(GHPS).&#xD;
Key findings: Data was collected for 491 patients&#xD;
(aged between18-98 years) were 272 (55%) were females&#xD;
and 10% (n = 47) were institutionalised. Eight percent&#xD;
(n=395) were prescribed drugs for cardiovascular diseases&#xD;
which constituted 50% of the total drug expenditure. Daily&#xD;
cost per patient was one euro. Pearson correlation value&#xD;
(p&lt;0.05) revealed a significant relationship between the&#xD;
increase in cost, unit doses and number of diseases with&#xD;
increasing age, between gender and different settings.&#xD;
Gender variation between drug categories was not&#xD;
significant (p&gt;0.05).&#xD;
Conclusions: Cost of drug treatment is vital&#xD;
information that financing providers and policy makers&#xD;
require for the allocation of budgets. Findings suggest&#xD;
that populations are ageing, cost increases with age and&#xD;
that gender and setting influence the treatment being&#xD;
provided.</description>
    <dc:date>2011-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://www.um.edu.mt/library/oar/handle/123456789/41037">
    <title>Evaluation of pharmacist clinical recommendations in a geriatric hospital</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/41037</link>
    <description>Title: Evaluation of pharmacist clinical recommendations in a geriatric hospital
Authors: Vella, Elaine; Azzopardi, Lilian M.
Abstract: Objectives: This study was undertaken to record&#xD;
the number and type of recommendations made by&#xD;
pharmacists reviewing the drug treatment of older&#xD;
patients, to note acceptance of these recommendations by&#xD;
physicians and to assess clinical significance of pharmacist&#xD;
recommendations.&#xD;
Method: Three pharmacists providing inpatient&#xD;
services at Zammit Clapp Hospital were asked to record&#xD;
specific details of all recommendations given using a&#xD;
designed documentation form. The clinical impact of&#xD;
the pharmacists’ recommendations was assessed by the&#xD;
pharmacists making the recommendations together&#xD;
with a panel of two independent pharmacists and a&#xD;
medical doctor who had to rate the contribution of each&#xD;
recommendation as major, moderate, minor or of no&#xD;
clinical significance.&#xD;
Key findings: A total of 263 valid pharmacist&#xD;
recommendations were documented. The most frequent&#xD;
recommendations, accounting for 20.5% (n=54) of the&#xD;
total number of recommendations were adjustment to&#xD;
dosage, frequency and time of administration followed&#xD;
by discontinuation of a medication. The majority of&#xD;
recommendations were accepted by physicians (80%) and&#xD;
were rated by the panel to be of moderate (60.5%) clinical&#xD;
significance.&#xD;
Conclusion: Clinical pharmacists make a number&#xD;
of recommendations of significant clinical benefit to the&#xD;
care of hospitalised elderly patients, the majority of which&#xD;
are accepted by physicians.</description>
    <dc:date>2011-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

